Recent Quotes (30 days)

You have no recent quotes
chg | %

AstraZeneca plc news

   Watch this stock
Showing stories 1 - 10 of about 49   

Articles published

AZN 4,519.68 -0.32 (-0.01%)
price chart
Amylin Said to Attract Interest From Pfizer, AstraZeneca
AstraZeneca Plc, the U.K.'s second-biggest drugmaker, shouldn't get a further reduction in an antitrust fine of 52.5 million euros ($67.5 million), an adviser to the European Union's highest court said.
Boards wake up to a shareholder spring
Two weeks ago David Brennan, chief executive of AstraZeneca, bowed to pressure from the pharmaceutical group's top shareholders and stepped down at the annual meeting.
US to partner with Big Pharma for drug discovery
The National Institutes of Health said on Thursday that Pfizer Inc, AstraZeneca Plc and Eli Lilly and Co have agreed to make 24 compounds available for a pilot phase of the project, the biggest of its kind ever launched in the United States.
US to Seek New Uses for Abandoned Drugs  Wall Street Journal
EU to push for binding investor pay votes
Shareholders in Europe's listed companies will be given a binding vote on pay while those who invest in banks will gain powers to set a cap on bonus levels, under plans being drawn up by senior EU officials.
Drugmakers see $33bn bout of M&A activity
While the appetite for “mega mergers” has dulled, several midsize companies including Shire and Biogen Idec are regularly cited as potential targets.
Aviva chief resigns after shareholder uprising
The resignation of Moss followed the high-profile exits of Sly Bailey from Trinity Mirror and David Brennan from AstraZeneca last week as a result of shareholder hostility. Aviva shares, which have fallen a third in a year, were up 4% on the news. Lord ...
UK Pay Protests Oust Aviva Chief  Wall Street Journal
EU Joins Widening Push to Find New Antibiotics
"Antibiotics are fundamental for the practice of medicine," says John Rex, vice-president of clinical infection at AstraZeneca PLC." Without them you cannot get your heart valve replaced, take care of a premature infant, get your cancer treated, or ...
Pendragon scraps executive pay plan after revolt
Last week, media doyen Sly Bailey went from Trinity Mirror and the week before AstraZeneca chief executive David Brennan resigned.
Did Say On Pay Cost A CEO His Job?
Likewise, at British drug maker AstraZeneca, CEO David Brennan announced two weeks ago that he would resign on June 1. AstraZeneca, hit by competition from generic drug manufacturers and the failure of several drugs in development, has seen shares ...
French Connection in two minutes
Stephen Marks, French Connection's (FCCN) chairman and chief executive, has just experienced the most difficult winter season in all his years in business.